Health technology assessment and policy from the economic perspective

International Journal of Technology Assessment in Health Care

Volumn 20, Issue 1, 2004, Pages 67-70

  Rutten, Frans ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Economics; Health technology assessment

Indexed keywords

COST EFFECTIVENESS; DECISION MAKING; ECONOMIC AND SOCIAL EFFECTS; PUBLIC POLICY;

HEALTH TECHNOLOGY ASSESSMENT (HTA); POLICY MAKING;

HEALTH CARE;

COST EFFECTIVENESS ANALYSIS; DECISION MAKING; ECONOMIC EVALUATION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH INSURANCE; MEDICAL TECHNOLOGY; REIMBURSEMENT; REVIEW;

EID: 2442686639     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462304000807     Document Type: Review

References (4)

1. Banta HD. Report from the EUR-ASSESS Project. Int J Technol Assess Health Care. 1997:13;133-143.
2. Herings RMC, Leufkens HGM, Heerding ER, Klungel OH, Breekveldt-Postma NS. Chronic pharmacotherapy forever. Utrecht: Pharmo Institute; 2002.
3. Hill SR, Mitchell AS, Henry DA. Problems with the interpretation of pharmacoeconomic analyses: A review of submissions to the Australian Pharmaceutical Benefits Scheme. JAMA. 2000:283;2116-2121.
4. Rutten F, van Busschbach J. How to define a basic package of health services for a tax funded or social insurance based health care system? Eur J Health Economics. 2001:2; 45-46.